Financial
CVC
UNITED KINGDOM WEBSITE : CVC.COM
CVC has established itself, over four decades, as one of the leading private equity investors. The platform has developed an integrated model structured around seven complementary strategies: Europe / Americas, Asia, Strategic Opportunities, Catalyst, Secondaries, Credit and Infrastructure, deployed within a single organisation mobilising more than 1,600 employees across 30 offices on six continents. The firm manages €212 billion in assets under management and backs more than 150 companies. At the heart of the buyout engine sits the Europe/Americas strategy, which captures the bulk of the capital with €84 billion in AUM and 91 active investments run by a team of 189 professionals; it favours control or co-control stakes in market-leading, cash-generating companies firmly anchored in defensible positions. CVC directs its investments primarily across the following sectors: food processing, life sciences, software, industrial services, industrial equipment and concentrates primarily on: United states, United kingdom and Italy, where its longstanding presence (21 offices across EMEA and the Americas) gives it proprietary sourcing. Recent transactions by the fund notably include Corbion, Cernaval and Fibrotex. The firm also highlights specific asset characteristics that underpin its investment thesis: predictable cash flows, diversified customer bases and defensible leadership positions, keeping market risk as a minimal component of each thesis. The average EBITDA multiple paid by CVC over the past 10 years stands at 13.5x.
CVC has established itself, over four decades, as one of the leading private equity investors. The platform has developed an integrated model structured around seven complementary strategies: Europe / Americas, Asia, Strategic Opportunities, Catalyst, Secondaries, Credit and Infrastructure, deployed within a single organisation mobilising more than 1,600 employees across 30 offices on six continents. The firm manages €212 billion in assets under management and backs more than 150 companies. At the heart of the buyout engine sits the Europe/Americas strategy, which captures the bulk of the capital with €84 billion in AUM and 91 active investments run by a team of 189 professionals; it favours control or co-control stakes in market-leading, cash-generating companies firmly anchored in defensible positions. CVC directs its investments primarily across the following sectors: food processing, life sciences, software, industrial services, industrial equipment and concentrates primarily on: United states, United kingdom and Italy, where its longstanding presence (21 offices across EMEA and the Americas) gives it proprietary sourcing. Recent transactions by the fund notably include Corbion, Cernaval and Fibrotex. The firm also highlights specific asset characteristics that underpin its investment thesis: predictable cash flows, diversified customer bases and defensible leadership positions, keeping market risk as a minimal component of each thesis. The average EBITDA multiple paid by CVC over the past 10 years stands at 13.5x.
48 Deals with CVC
| Date | Type | Target | Acquirer | Sector | Rev | EBITDA | EV | xRev | xEBITDA |
|---|---|---|---|---|---|---|---|---|---|
| 06/2026 | Minority | Chess.com UNITED STATES | CVC | Gaming & Consumer Apps | |||||
| 06/2026 | 100% Acquisition | Clevertech ITALY | CVC | Special Machinery | |||||
| 05/2026 | Majority | IFF Food Ingredients UNITED STATES | CVC | Ingredients | |||||
| 02/2026 | Majority | DSM-Firmenich Anh (Animal Nutrition & Health) SWITZERLAND | CVC | Specialty Chemicals | |||||
| 01/2026 | Majority | Celeste FRANCE | CVC | Telecom | |||||
| 12/2025 | 100% | Smiths Detection UNITED KINGDOM | CVC | Safety & Security | |||||
| 10/2025 | Majority | Bamboo UNITED STATES | CVC | Insurance | |||||
| 10/2025 | 100% | Manx Telecom UNITED KINGDOM | JT Group / CVC | Operators | |||||
| 10/2025 | Minority | International Schools Partnership UNITED KINGDOM | CVC | Education Providers | |||||
| 11/2024 | 100% | Therakos UNITED STATES | CVC | Medical Devices | |||||
| Average (10 yrs) | 2.8x | 13.5x | |||||||
| Median (10 yrs) | 2.5x | 12.3x | |||||||
